HedgePath Pharmaceuticals, Inc. 4
4 · HedgePath Pharmaceuticals, Inc. · Filed Mar 10, 2017
Insider Transaction Report
Form 4
Hasara Garrison J.
CEO, Secretary & Treasurer
Transactions
- Tax Payment
Common Stock
2017-03-08$0.34/sh−1,470,478$499,963→ 4,059,044 total - Exercise/Conversion
Common Stock
2017-03-08+3,500,000→ 5,529,522 total - Exercise/Conversion
Restricted Stock Units
2017-03-08−3,500,000→ 0 total→ Common Stock (3,500,000 underlying) - Exercise/Conversion
Common Stock
2017-03-08+3,500,000→ 3,500,000 total - Tax Payment
Common Stock
2017-03-08$0.34/sh−1,470,478$499,963→ 2,029,522 total - Exercise/Conversion
Restricted Stock Units
2017-03-08−3,500,000→ 0 total→ Common Stock (3,500,000 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a right to receive one share of the issuer's common stock.
- [F2]The RSUs were issued to the reporting person on August 6, 2014, pursuant to a grant under the issuer's 2014 Equity Incentive Plan, and vested in accordance with their terms.